Abcam (ABCZF) Stock Price, News & Analysis

Company Overview

Abcam Limited, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. The company's principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, biochemicals, and cell signaling pathway tools. It serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. The company has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. It sells its products online. Abcam Limited was formerly known as Abcam plc and changed its name to Abcam Limited in December 2023. The company was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom. As of December 6, 2023, Abcam Limited operates as a subsidiary of Danaher Corporation.

Key Stats

• Today's Range: C$22.25 to C$22.25
• 50-Day Range: C$22.25 to C$22.25
• 52-Week Range: C$5.00 to C$23.80
• Volume: N/A
• Average Volume: 2,659 shs
• Market Capitalization: N/A
• P/E Ratio: 130.73
• Dividend Yield: 0.32%
• Price Target: N/A
• Consensus Rating: N/A

ABCZF Stock Analysis - Frequently Asked Questions

How have ABCZF shares performed this year?

Abcam's stock was trading at C$22.25 at the beginning of 2025. Since then, ABCZF stock has increased by 0.0% and is now trading at C$22.25.
View the best growth stocks for 2025 here.

How do I buy shares of Abcam?

Shares of ABCZF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:ABCZF
• CIK: 1492074
• Web: abcam.com
• Phone: 441223696000
• Fax: N/A
• Employees: 1,750
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: 130.73
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A